Skip to main content
Premium Trial:

Request an Annual Quote

Ionian Technologies Gets Gates Funding for MDx Platform

NEW YORK (GenomeWeb News) – Ionian Technologies today said that it has received additional funding from the Bill & Melinda Gates Foundation to continue developing a molecular diagnostics platform designed for use in the developing world.

The San Diego-based firm said that its total commitment from the Gates foundation has risen to $3 million over two years.

Ionian is using the funds to develop a platform based on its isothermal nucleic acid amplification (NEAR) technology. It intends to initially develop assays for the platform that will detect tuberculosis, Chlamydia, and gonorrhea.

The NEAR technology can detect either DNA or RNA from bacterial or viral pathogens with a five-minute amplification coupled with a simple and rapid detection by fluorescence or lateral-flow test strips. The firm claims that the NEAR amplification reaction matches the sensitivity and specificity performance of current nucleic acid technologies such as PCR, but in less time and with a less complicated handheld device.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.